Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on New Jersey Health Reporter.
Press releases published on August 20, 2025
Eton Pharmaceuticals to Participate at 2025 Wells Fargo Healthcare Conference
GlobeNewswire
·
August 20, 2025
DEER PARK, Ill., Aug. 20, 2025 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (“Eton” or the “Company”) (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases, today announced that members …
Global Hearing Aids Market to Surpass USD 14.42 Billion by 2030 | MarketsandMarkets™
GlobeNewswire
·
August 20, 2025
Delray Beach, FL, Aug. 20, 2025 (GLOBE NEWSWIRE) -- Growing Prevalence of Hearing Loss and Smart Technology Adoption Fuel Sector Expansion The global hearing aids market, valued at US$9.74 billion in 2024, stood at US$10.35 billion in 2025 and is projected …
Sai Life Sciences secures SBTi validation for near-term climate targets
GlobeNewswire
·
August 20, 2025
HYDERABAD, India, Aug. 20, 2025 (GLOBE NEWSWIRE) -- Sai Life Sciences Limited (BSE: 544306 I NSE: SAILIFE), an innovator focused Contract Research, Development, and Manufacturing Organization (CRDMO), announced that its near-term targets to cut greenhouse …
Healthletic Reports 91% of Users Experience Noticeable Energy Boost with USP-Grade Methylene Blue Formula
GlobeNewswire
·
August 20, 2025
Texas, USA, Aug. 20, 2025 (GLOBE NEWSWIRE) -- Healthletic, a premier U.S.-based wellness supplement manufacturer, today released comprehensive user outcome data revealing that 91% of customers using its Ultimate Methylene Blue drops reported experiencing a …
HUTCHMED Completes Patient Enrollment of SANOVO Phase III Trial of ORPATHYS® and TAGRISSO® Combination as a First-Line Therapy for Certain Lung Cancer Patients in China
GlobeNewswire
·
August 20, 2025
HONG KONG and SHANGHAI and FLORHAM PARK, N.J., Aug. 20, 2025 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM:HCM; HKEX:13) today announces the completion of patient enrollment of SANOVO, a China Phase III study of ORPATHYS® ( …